Cargando…
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954510/ https://www.ncbi.nlm.nih.gov/pubmed/31924240 http://dx.doi.org/10.1186/s13054-019-2724-y |
_version_ | 1783486807998988288 |
---|---|
author | Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, Jose A. Alós, Manuel Navarro, David |
author_facet | Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, Jose A. Alós, Manuel Navarro, David |
author_sort | Aguilar, Gerardo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6954510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69545102020-01-14 Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, Jose A. Alós, Manuel Navarro, David Crit Care Letter BioMed Central 2020-01-10 /pmc/articles/PMC6954510/ /pubmed/31924240 http://dx.doi.org/10.1186/s13054-019-2724-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, Jose A. Alós, Manuel Navarro, David Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title | Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title_full | Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title_fullStr | Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title_full_unstemmed | Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title_short | Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
title_sort | optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954510/ https://www.ncbi.nlm.nih.gov/pubmed/31924240 http://dx.doi.org/10.1186/s13054-019-2724-y |
work_keys_str_mv | AT aguilargerardo optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT ferriolsrafael optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT martinezcastrosara optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT ezquercarlos optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT pastorernesto optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT carbonelljosea optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT alosmanuel optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances AT navarrodavid optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances |